GO:0002528 regulation of vascular permeability involved in acute inflammatory response: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002528 describes the biological process that modulates how easily blood vessel walls are pervaded by fluid during an acute inflammatory response.
• The process is driven by endothelial barrier disruption, mediated by histamine, arachidonic acid metabolites, and plasma proteases that cleave junctional and structural proteins [1,5].
• Key molecular players include MERTK, FAK, PLVAP, and S1P receptors, which regulate endothelial cell contraction, junctional stability, and vesicular transport [3,6,8].
• Dysregulation of vascular permeability contributes to acute lung injury, ARDS, traumatic shock, and inflammatory tissue damage [4,7].
• CRISPR knockout, point-mutation, and knock-in models are essential to dissect causal roles of individual genes in this process [6,8].
• Targeting this pathway offers therapeutic potential for diseases characterized by vascular leak and edema [2,4].
Description
The Gene Ontology term GO:0002528, regulation of vascular permeability involved in acute inflammatory response, defines any process that modulates the extent to which blood vessels can be pervaded by fluid contributing to an acute inflammatory response. This process is a critical component of innate immunity, allowing plasma proteins and leukocytes to reach sites of infection or injury, but when uncontrolled it leads to edema, tissue damage, and organ dysfunction [2,4]. Researchers study this term to understand the molecular checkpoints that govern endothelial barrier function during inflammation, with implications for acute lung injury, sepsis, and trauma [4,7]. The regulation involves a complex interplay of vasoactive mediators, endothelial cell signaling, and structural changes in the vascular wall [1,3,5]. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of the mechanisms, genes, and experimental models relevant to GO:0002528.
regulation of vascular permeability involved in acute inflammatory response At A Glance
| GO ID | GO:0002528 |
|---|---|
| GO term | regulation of vascular permeability involved in acute inflammatory response |
| Ontology | biological_process |
| Synonym | regulation of vascular permeability during acute inflammatory response |
| Major function | Modulates the extent to which blood vessels are pervaded by fluid during acute inflammation |
| Related processes | Endothelial barrier function, leukocyte extravasation, edema formation |
| Key mediators | Histamine, arachidonic acid metabolites, S1P, plasma proteases |
| Cellular location | Endothelial cell junctions, plasma membrane, vesicular compartments |
What Is GO:0002528?
GO:0002528 is a biological process that encompasses any molecular event that modulates the permeability of blood vessels to fluid during an acute inflammatory response. It is not a static property but a dynamic regulatory process that can increase or decrease vascular leak in response to inflammatory stimuli.
Why Is regulation of vascular permeability involved in acute inflammatory response Important in Cell Biology?
Regulation of vascular permeability is a double-edged sword in acute inflammation: it is essential for delivering immune cells and plasma proteins to injured tissues, but excessive or prolonged permeability causes life-threatening edema and organ failure [2,4]. Understanding this process at the molecular level is critical for developing therapies for acute lung injury, ARDS, sepsis, and traumatic shock [4,7].
• Controls the delivery of immune cells and plasma proteins to sites of infection or injury.
• Dysregulation leads to edema, tissue hypoxia, and organ dysfunction in acute lung injury and ARDS.
• Plays a central role in the pathophysiology of traumatic shock and systemic inflammatory response syndrome.
• Involves endothelial cell signaling pathways that are amenable to pharmacological intervention.
• Serves as a model for studying endothelial barrier biology and cell-cell junction dynamics.
• Key genes such as MERTK and FAK are potential therapeutic targets for inflammatory diseases [6,8].
• Histamine and arachidonic acid metabolites are well-characterized mediators that can be targeted [1,5].
• PLVAP is a structural component of endothelial fenestrae and regulates permeability.
What Happens During regulation of vascular permeability involved in acute inflammatory response?
Initiation by Vasoactive Mediators
In simple terms: Inflammation triggers the release of chemicals that make blood vessels leaky.
Upon tissue injury or infection, mast cells and other immune cells release histamine, which binds to H1 receptors on endothelial cells and triggers rapid, transient increases in vascular permeability. Arachidonic acid metabolites, such as prostaglandins and leukotrienes, also contribute to sustained permeability changes. These mediators act on endothelial cells to initiate cytoskeletal rearrangement and junctional disruption.
Endothelial Cell Contraction and Junctional Disruption
In simple terms: Endothelial cells pull apart, opening gaps between them.
Histamine and other mediators induce endothelial cell contraction through actin-myosin-based mechanisms, leading to the opening of intercellular junctions. This process involves phosphorylation of myosin light chain and reorganization of the actin cytoskeleton. Focal adhesion kinase (FAK) plays a critical role in integrating signals from S1P receptors to regulate junctional stability and permeability.
Vesicular Transport and Transcytosis
In simple terms: Cells actively shuttle fluid and proteins across their interior.
In addition to paracellular gaps, endothelial cells can increase permeability through transcytosis, a process involving vesicular carriers such as caveolae. PLVAP (plasmalemma vesicle-associated protein) is a key component of endothelial fenestrae and stomatal diaphragms, and its expression is regulated during inflammation to modulate transendothelial transport.
Resolution and Barrier Restoration
In simple terms: The leak is sealed off once the threat is contained.
After the inflammatory stimulus is cleared, permeability is restored through re-annealing of junctions and stabilization of the endothelial barrier. MERTK, a receptor tyrosine kinase, promotes endothelial barrier integrity and resolution of inflammation in the lungs. S1P signaling through FAK also contributes to barrier restoration.
Key Genes Involved in GO:0002528 regulation of vascular permeability involved in acute inflammatory response
The following genes and proteins are central to the regulation of vascular permeability during acute inflammation, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| H1 receptor (HRH1) | Binds histamine to trigger endothelial contraction and permeability | Target for antihistamines in acute inflammation |
| MERTK | Promotes endothelial barrier integrity and resolution of inflammation | Knockout models show delayed barrier restoration |
| FAK (PTK2) | Integrates S1P signaling to regulate junctional stability | Phosphorylation mutants reveal permeability control |
| PLVAP | Structural component of endothelial fenestrae and vesicular transport | Regulates transcytosis and permeability |
| S1PR1 | G-protein coupled receptor for S1P that enhances barrier function | Agonists/antagonists modulate permeability |
| COX-2 (PTGS2) | Produces prostaglandins from arachidonic acid | Inhibitors reduce inflammatory permeability |
| 5-LOX (ALOX5) | Produces leukotrienes that increase permeability | Target for anti-inflammatory drugs |
| VE-cadherin (CDH5) | Adherens junction protein maintaining endothelial barrier | Cleavage by proteases increases permeability |
| ZO-1 (TJP1) | Tight junction protein linking junctions to cytoskeleton | Phosphorylation regulates barrier function |
| Claudin-5 (CLDN5) | Tight junction protein controlling paracellular permeability | Knockdown increases leak |
| RhoA | GTPase regulating actin cytoskeleton and contraction | Dominant-negative mutants stabilize barrier |
| ROCK1 | Effector of RhoA that promotes contraction | Inhibitors reduce permeability |
| MLCK (MYLK) | Phosphorylates myosin light chain to drive contraction | Knockout prevents junctional opening |
| PLCβ | Produces IP3 and DAG downstream of histamine | Modulates calcium signaling |
| eNOS (NOS3) | Produces NO that can modulate permeability | Inhibitors show context-dependent effects |
| NF-κB | Transcription factor driving expression of inflammatory mediators | Inhibition reduces permeability |
| TNF-α | Cytokine that increases endothelial permeability | Neutralizing antibodies reduce leak |
| IL-1β | Cytokine that promotes endothelial activation | Receptor antagonists modulate permeability |
How Is regulation of vascular permeability involved in acute inflammatory response Regulated?
The process is regulated by a balance of barrier-protective and barrier-disruptive signals. S1P binding to S1PR1 enhances barrier function through FAK-dependent signaling. MERTK activation promotes barrier integrity and resolution of inflammation. In contrast, histamine and arachidonic acid metabolites trigger contraction and junctional opening [1,5]. Transcriptional regulation by NF-κB and cytokines such as TNF-α and IL-1β amplifies the inflammatory response.
regulation of vascular permeability involved in acute inflammatory response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MERTK | Acute lung injury, impaired barrier resolution | Endothelial-specific knockout mouse |
| FAK (PTK2) | ARDS, S1P-regulated permeability | Phosphorylation-deficient knock-in mouse |
| PLVAP | Vascular leak, transcytosis dysregulation | PLVAP knockout zebrafish or mouse |
| HRH1 | Histamine-induced edema, anaphylaxis | H1 receptor knockout mouse |
| ALOX5 | Neuroinflammation, leukotriene-mediated permeability | 5-LOX knockout mouse |
Acute Lung Injury and ARDS
Dysregulated vascular permeability is a hallmark of acute lung injury and acute respiratory distress syndrome (ARDS), leading to protein-rich edema fluid in the alveoli and impaired gas exchange. Pulmonary endothelial barrier dysfunction involves disruption of adherens and tight junctions, as well as increased transcytosis. MERTK and FAK are potential therapeutic targets to restore barrier integrity [6,8].
Traumatic Shock and Systemic Inflammation
In traumatic shock, widespread vascular permeability contributes to hypovolemia, tissue edema, and multiple organ failure. The pathophysiology involves release of histamine and other mediators that systemically increase endothelial permeability [1,7]. Understanding the regulation of vascular permeability is critical for developing resuscitation strategies.
Neurologic Disorders
Arachidonic acid metabolites, which regulate vascular permeability, are implicated in neurologic disorders such as stroke and neuroinflammation. Breakdown of the blood-brain barrier, a specialized form of vascular permeability regulation, contributes to neuronal damage. Targeting these pathways may offer neuroprotective strategies.
From regulation of vascular permeability involved in acute inflammatory response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MERTK regulate endothelial barrier restoration? | Endothelial-specific MERTK knockout mouse |
| How does FAK phosphorylation control S1P-mediated permeability? | FAK point-mutation knock-in (e.g., Y397F) |
| What is the role of PLVAP in transcytosis? | PLVAP knockout zebrafish or mouse |
| Can H1 receptor antagonists reduce acute permeability? | H1 receptor knockout mouse |
| Does 5-LOX inhibition reduce neuroinflammation? | 5-LOX knockout mouse |
| Is VE-cadherin cleavage required for permeability? | VE-cadherin cleavage-resistant knock-in mouse |
How to Study the regulation of vascular permeability involved in acute inflammatory response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Evans blue extravasation | Vascular leak in vivo | Acute inflammation models [1,4] |
| TEER | Endothelial barrier integrity | In vitro permeability studies |
| FITC-dextran flux | Paracellular permeability | Monolayer assays |
| Confocal imaging | Junctional protein localization | VE-cadherin dynamics [2,3] |
| Phosphoproteomics | Signaling changes | FAK, MLCK activation |
| RNA-seq | Transcriptional responses | Inflammatory gene expression |
| Miles assay | Local vascular permeability | Skin inflammation models |
| Intravital microscopy | Real-time leukocyte-endothelial interactions | Permeability and extravasation |
In Vivo Permeability Assays
Evans blue dye extravasation and Miles assay are classic methods to measure vascular permeability in animal models [1,4]. These assays quantify leakage of albumin-bound dye into tissues after inflammatory challenge.
Endothelial Barrier Function In Vitro
Transendothelial electrical resistance (TEER) and flux assays using FITC-dextran measure barrier integrity in cultured endothelial cells. These methods allow precise manipulation of signaling pathways.
Imaging of Junctional and Cytoskeletal Dynamics
Confocal and live-cell imaging of VE-cadherin, ZO-1, and actin allows visualization of junctional disruption and cell contraction [2,3]. Fluorescently tagged proteins in knockout or knock-in cells reveal real-time changes.
Genomic and Proteomic Profiling
RNA-seq and phosphoproteomics identify transcriptional and post-translational changes in endothelial cells during inflammation [6,8]. These approaches can uncover novel regulators of permeability.
How CRISPR Can Be Used to Study GO:0002528 regulation of vascular permeability involved in acute inflammatory response
Knockout
CRISPR knockout of genes such as MERTK, FAK, or PLVAP in endothelial cells or mouse models can reveal their causal role in regulating vascular permeability [3,6,8]. For example, MERTK knockout mice show impaired barrier resolution in acute lung injury.
Point Mutation
Point mutations can dissect specific phosphorylation sites or catalytic residues. For instance, FAK Y397F knock-in prevents autophosphorylation and alters S1P-mediated permeability. Such models provide mechanistic insights beyond simple knockout.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags allows real-time imaging of junctional proteins like VE-cadherin or PLVAP. This approach visualizes dynamic changes during inflammation.
Overexpression
Overexpression of barrier-protective genes such as MERTK or S1PR1 can enhance endothelial barrier function and reduce permeability [6,8]. Conversely, overexpression of permeability-inducing genes can model disease states.
How EDITGENE Supports regulation of vascular permeability involved in acute inflammatory response Research
Researchers studying regulation of vascular permeability involved in acute inflammatory response-related genes often need to determine whether a candidate gene is causally involved in barrier disruption or restoration. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for regulation of vascular permeability involved in acute inflammatory response research.
Frequently Asked Questions About regulation of vascular permeability involved in acute inflammatory response
What is GO:0002528?
GO:0002528 is the Gene Ontology term for regulation of vascular permeability involved in acute inflammatory response, a biological process that modulates how easily blood vessels are pervaded by fluid during acute inflammation.
What genes are involved in regulation of vascular permeability involved in acute inflammatory response?
Key genes include MERTK, FAK (PTK2), PLVAP, HRH1, S1PR1, and ALOX5, among others [1,3,5,6,8].
How does histamine increase vascular permeability?
Histamine binds H1 receptors on endothelial cells, triggering contraction and junctional opening, leading to increased permeability.
What is the role of FAK in vascular permeability?
FAK integrates S1P signaling to regulate endothelial junctional stability and permeability.
How is vascular permeability measured in research?
Common methods include Evans blue extravasation, TEER, and FITC-dextran flux assays [1,4,8].
What diseases are associated with dysregulated vascular permeability?
Acute lung injury, ARDS, traumatic shock, and neuroinflammatory disorders are associated with dysregulated vascular permeability [4,5,7].
What is the role of PLVAP in endothelial cells?
PLVAP is a structural component of endothelial fenestrae and stomatal diaphragms, regulating transendothelial transport.
Can CRISPR be used to study vascular permeability genes?
Yes, CRISPR knockout, point mutation, and knock-in models are widely used to dissect gene function in vascular permeability [3,6,8].
What is MERTK's function in inflammation?
MERTK promotes endothelial barrier integrity and resolution of inflammation in the lungs.
How does S1P regulate vascular permeability?
S1P binding to S1PR1 enhances endothelial barrier function through FAK-dependent signaling.
Conclusion
GO:0002528, regulation of vascular permeability involved in acute inflammatory response, is a critical biological process that balances immune surveillance and tissue homeostasis. Its dysregulation underlies major human diseases such as ARDS and traumatic shock [4,7]. Continued research using CRISPR models and advanced imaging will uncover new therapeutic targets to modulate vascular permeability [3,6,8].
References
- 1. Patel RH et al.. 2026. Biochemistry, Histamine.. PMID: 32491722
- 2. Lentsch AB et al.. 2000. Regulation of inflammatory vascular damage.. J Pathol 190(3):343-8 PMID: 10685068
- 3. Denzer L et al.. 2023. The role of PLVAP in endothelial cells.. Cell Tissue Res 392(2):393-412 PMID: 36781482
- 4. Su Y et al.. 2024. Mechanisms of pulmonary endothelial barrier dysfunction in acute lung injury and acute respiratory distress syndrome.. Chin Med J Pulm Crit Care Med 2(2):80-87 PMID: 39006829
- 5. Kursun O et al.. 2022. Arachidonic Acid Metabolites in Neurologic Disorders.. CNS Neurol Disord Drug Targets 21(2):150-159 PMID: 33982658
- 6. Li Y et al.. 2019. The role of endothelial MERTK during the inflammatory response in lungs.. PLoS One 14(12):e0225051 PMID: 31805065
- 7. Fabiano G et al.. 2008. [Traumatic shock--physiopathologic aspects].. G Chir 29(1-2):51-7 PMID: 18252151
- 8. Belvitch P et al.. 2012. Role of FAK in S1P-regulated endothelial permeability.. Microvasc Res 83(1):22-30 PMID: 21925517
